Impact of pharmaceutical promotion on prescribing decisions of general practitioners in Eastern Turkey

BMC Public Health

Volumn 7, Issue , 2007, Pages

  Vancelik, Serhat ^a   Beyhun, Nazim E ^a   Acemoglu, Hamit ^a   Calikoglu, Oksan ^a  

^a ATATURK UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PRACTICE; CONTROLLED STUDY; DEMOGRAPHY; DRUG INDUSTRY; DRUG SELF ADMINISTRATION; FEMALE; GENERAL PRACTITIONER; HEALTH SURVEY; HUMAN; MALE; MEDICAL DECISION MAKING; MEDICAL EDUCATION; NORMAL HUMAN; PATIENT CARE; PRESCRIPTION; PRIMARY HEALTH CARE; REVIEW; SELF REPORT; STRUCTURED QUESTIONNAIRE; TURKEY (REPUBLIC); ADULT; ARTICLE; CHI SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDY; DECISION MAKING; DRUG COST; DRUG UTILIZATION; ECONOMICS; GENERAL PRACTICE; HEALTH SERVICE; MARKETING; MIDDLE AGED; QUESTIONNAIRE; STATISTICS;

ADULT; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; DECISION MAKING; DRUG COSTS; DRUG INDUSTRY; DRUG UTILIZATION; FAMILY PRACTICE; FEMALE; HUMANS; MALE; MARKETING; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTIONS, DRUG; QUESTIONNAIRES; TURKEY; URBAN HEALTH SERVICES;

EID: 34447276404     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-7-122     Document Type: Review

References (32)

1. Lessons from international experience in controlling pharmaceutical expenditure II: Influencing doctors. K Bloor N Freemantle, BMJ 1996 312 1525 1527 8646148
2. Problems of Irrational Drug Use-Session Guide. http://dcc2.bumc.bu.edu/ prdu/Session_Guides/problems_of_irrational_drug_use.htm (01.06.2006)
3. Dangerous liaisons-physicians and pharmaceutical sales representatives. M Granja, Acta Med Port 2005 18 1 61 68 16202335
4. Cost to patient or cost to the healthcare system? Which one matters the most for GP prescribing decisions? A UK-Italy comparison. K Hassel V Atella EI Schafheutle MC Weiss PR Noyce, Eur J Public Health 2003 13 1 18 23 10.1093/eurpub/13.1.18 12678309
5. Physicians choose drugs. P Denig FM Haajer-Ruskamp Hox DH Zijsling, Soc Sci Med 1998 7 1381 1386
6. Is general practitioner decision making associate with patient socio-economic status? A Scott A Shiell M King, Soc Sci Med 1996 42 35 46 10.1016/0277-9536(95)00063-1 8745106
7. Influences of practice characteristic on prescribing in fundholding and non - fundholding general practices. R Wilson J Hatcher S Barton T Walley, BMJ 1996 313 595 599 8806250
8. Influences on GPs' decision to prescribe new drugs - the importance of who says what. H Prosser S Almond T Walley, Family Practice 2003 20 1 61 8 10.1093/fampra/20.1.61 12509373
9. Scientific versus commercial sources of influence on the prescribing behaviour of physicians. J Avorn M Chen R Hartley, Am J Med 1982 73 4 8 10.1016/0002-9343(82)90911-1 7091173
10. Prescribers prefer people: the sources of information used by doctors for prescribing suggest that the medium is more important than the message. P Mc Gettigan J Golden J Fryer R Chan J Feely, Br J Clin Pharmacol 2001 51 184 89 10.1111/j.1365-2125.2001.01332.x 11259994
11. Physicians and the pharmaceutical industry: is a gift ever just a gift? A Wazana, JAMA 2000 283 373 380 10.1001/jama.283.3.373 10647801
12. How to investigate drug use in health facilities: selected drug use indicators. World Health Organization Action Programme on Essential Drugs. Geneva, (WHO/DAP/93.1) 1993
13. Prescribing new drugs: qualitative study of influences on consultant and general practitioners. MI Jones SM Greenfield CP Bradley, BMJ 2001 323 378 11509431 10.1136/bmj.323.7309.378
14. Why general practitioners and consultants change their clinical pactice: A critical incident study. LA Allery PA Owen MR Robling, BMJ 1997 314 870 874 9093100
15. General practitioners' perceptions of effective healthcare. Z Tomlin C Humphrey S Rogers, BMJ 1999 318 1532 1535 10356011
16. Questioning behaviour in general practice:A pragmatic study. AR Barrie AM Ward, BMJ 1997 315 1512 1515 9420495
17. Physcians-industry relations. SL Coyle, Ann Intern Med 2002 136 5 396 406 11874314
18. Fisons investigates claims of excessive hospitality. S Kingman, BMJ 1993 307 6915 1301 1302 11643188
19. Patient demand for prescriptions:a view from other side. N Britten, Fam Pract 1994 11 62 66 10.1093/fampra/11.1.62 8034154
20. Physician and the pharmacentical industry:a dysfunctional relationship. M Fisher, Perspect Biol Med 2003 46 2 254 272 10.1353/pbm.2003.0019 12721524
21. Doctors and drug companies. D Blumenthal, New Eng J Med 2004 357 18 1885 1990 10.1056/NEJMhpr042734
22. A review of factors influencing drug prescribing (I). RJ Plumridge, Aut J Hosp Pharm 1983 13 44 48
23. Incentivos de la Indestria farmaceutica a los medicos:problemas eticos, limitesy alternativas. A Figueiras F Caamano JJ Gestal-Otero, Gac Sanit 1997 11 297 300 9580191
24. Sources of information about new drugs and attitudes towards drug prescribing: an international study of differences between primary care physicians. FM Hull T Marshall, Fam Pract 1998 4 2 123 128 10.1093/fampra/4.2. 123
25. Execuitive Board 115th Session Summary Records. World Health Organization. Geneva, (EB115/2005/Rec/2:184-85) 2005
26. Rational prescribing in primary care: a new role for the clinical pharmacologist? T Walley, Br Med J 1993 36 11 12
27. Impact of a short postgraduate course in rational pharmacotherapy for general practitioners. A Akici S Kalaca MU Ugurlu A Karaalp S Cali S Oktay, Br J Clin Pharmacol 2004 57 3 310 321 10.1046/j.1365-2125.2003.02010.x 14998427
28. Effectiveness of the combination of feedback and educational recommendations for improving drug prescription in general practice. R Madridejos-Mora E Amado-Guirado MT Perez-Rodriguez, Med Care 2004 42 7 643 648 10.1097/01.mlr.0000129495.43422.58 15213488
29. Circulation of pharmaceutical information among general practitioners in the region of Sousse (Tunisia). A Ben Abdelaziz I Harrabi S Rahmani R Gaha H Ghannem, Therapie 2002 57 3 229 235 12422532
30. Physicians' behavior and their interactions with drug companies. M Cheren S Landefeld, JAMA 1994 217 684 689 10.1001/jama.271.9.684
31. Doctors and detailers. Theapeutic education or pharmaceutical promotion. J Lexchin, Int J Health Serv 1989 19 4 663 680 10.2190/HUFK-5Y54-QX1E-AD62 2583883
32. A study of factors associated with cost and variation in prescribing among GPs. P Carthy I Harvey R Brawn C Watkins, Fam Pract 2000 17 1 36 41 10.1093/fampra/17.1.36 10673486